On Monday, HCA Healthcare cleared a noteworthy performance benchmark, seeing its Relative Strength (RS) Rating jump into the 80-plus percentile with an improvement to 81, up from 78 the day before.
Looking For The Best Stocks To Buy And Watch? Start Here
IBD's unique RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that shows how a stock's price action over the last 52 weeks matches up against that of all other stocks.
History shows that the best stocks often have an 80 or better RS Rating in the early stages of their moves.
HCA Healthcare is working on a consolidation with a 417.14 buy point. See if the stock can clear the breakout price in heavy volume.
HCA Healthcare showed 5% EPS growth in its most recent report, while sales growth came in at 6%. The company is expected to report its latest numbers on or around Apr. 25.
The company earns the No. 4 rank among its peers in the Medical-Hospitals industry group. Nutex Health is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
